58 results
S-8
EX-4.2
VKTX
Viking Therapeutics Inc
22 May 24
Registration of securities for employees
4:33pm
(including any governmental division, department, administrative agency or bureau, commission, authority, instrumentality, official, ministry, fund
S-8
EX-4.6
VKTX
Viking Therapeutics Inc
22 May 24
Registration of securities for employees
4:33pm
, department, administrative agency or bureau, commission, authority, instrumentality, official, ministry, fund, foundation, center, organization
8-K
EX-99.1
VKTX
Viking Therapeutics Inc
4 Mar 24
Other Events
4:52pm
and the accompanying prospectus relating to the offering may also be obtained by contacting Morgan Stanley & Co. LLC, Attention: Prospectus Department, 180 Varick … Street, 2nd Floor, New York, NY 10014, or by email at prospectus@morganstanley.com; or Leerink Partners LLC, Attention: Syndicate Department, 53
8-K
EX-99.1
1mftukbxc
1 Mar 24
Viking Therapeutics Announces Pricing of $550 Million Public Offering of Common Stock
4:05pm
8-K
EX-1.1
pe78jlbg5a
1 Mar 24
Viking Therapeutics Announces Pricing of $550 Million Public Offering of Common Stock
4:05pm
PRE 14A
qor9 ifq7bn
17 Apr 23
Preliminary proxy
5:04pm
8-K
EX-99.1
aikdk1 62
3 Apr 23
Viking Therapeutics Announces Closing of Public Offering of Common Stock And Full Exercise of Underwriters’ Option to Purchase Additional Shares
5:17pm
8-K
EX-99.1
mfln0xn34vm i5y0bn5
31 Mar 23
Viking Therapeutics Announces Pricing of $250 Million Public Offering of Common Stock
5:27pm
8-K
EX-1.1
lsz zt2coss7bhf
31 Mar 23
Viking Therapeutics Announces Pricing of $250 Million Public Offering of Common Stock
5:27pm